Effect of Selenium Intervention on Inflammation in Older Adults
Stopped early · Not applicable · Has a placebo group
Conditions studied: Inflammation
In brief
Serum levels of inflammatory mediators increase with age and are strongly associated with the most common and the most devastating health conditions found in older adults including frailty, chronic disease, disability and increased mortality. Even though the processes that contribute to increased inflammatory mediators are likely not completely reversible in older adults, the development of a safe and effective intervention that modulates inappropriate inflammatory responses could be a very important component of prevention against frailty and other adverse health outcomes. As part of an ongoing effort to identify molecular and physiologic triggers of inflammation in older adults, the investigators recently identified a highly significant inverse relationship between the anti-oxidant micronutrient selenium and the inflammatory mediator IL-6, as well as a significant relationship between selenium and all cause mortality in a population of community dwelling older women with selenium levels well below the mean for the overall American population. Based on our findings in older adults and on data from other studies that suggest that selenium interventions are effective in targeted populations with inflammatory conditions, the investigators hypothesize that selenium supplementation targeted to a population of older adults with increased inflammatory markers and low normal selenium levels will in the short term reduce inflammation as measured by serum IL-6, and in the long term will reduce the incidence and prevalence of inflammation associated poor health outcomes of frailty, disability, and mortality in vulnerable older adults.
Key facts
- Study ID
- NCT01289925
- Run by
- Johns Hopkins University
- People needed
- 182
- Starts
- 2006-02-01
- Expected to finish
- 2012-01-20
- Last updated by the study team
- 2018-04-09
Who can join
Age: 70 and older, up to 110. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- 70 years of age or older
- Able to provide written informed consent for screening and participation in the study
You may not qualify if…
- Taking a multi-vitamin containing 60 ug or more of Selenium more than once a week
- Have evidence of an active, untreated, acute inflammatory disease state such as rheumatoid arthritis, gout, or malignancy
- Taking any corticosteroids or the medications prednisone or methotrexate
Where it is running
- Johns Hopkins Bayview Medical Center — Baltimore, Maryland, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.